Holding(s) in Company
January 21 2009 - 6:28AM
UK Regulatory
TIDMNPH TIDMLLOY
RNS Number : 0093M
Neuropharm Group PLC
21 January 2009
+-----------------------------------+------------------------------------------+
| For immediate release | 21 January 2009 |
+-----------------------------------+------------------------------------------+
Neuropharm Group plc
("Neuropharm" or the "Company")
TR-1: Notification of Major Interests in Shares
+------------------------------------------------+------------------------+--------+
| 1. Identity of the issuer or the underlying | Neuropharm Group plc |
| issuer of existing shares to which voting | |
| rights are attached: | |
+------------------------------------------------+---------------------------------+
| 2. Reason for the notification | |
+-------------------------------------------------------------------------+--------+
| Other (please specify): Disclosure of holdings following the | YES |
| acquisition, by Lloyds Banking Group plc, of HBOS plc - this | |
| notification supersedes any notifications previously issued by HBOS | |
| plc. | |
+-------------------------------------------------------------------------+--------+
| 3. Full name of person(s) subject to the | Lloyds Banking Group plc |
| notification obligation: | |
+------------------------------------------------+---------------------------------+
| 4. Full name of shareholder(s) (if different | See Section 9. |
| from 3.): | |
+------------------------------------------------+---------------------------------+
| 5. Date of the transaction (and date on which | 16 January 2009 |
| the threshold is crossed or reached if | |
| different): | |
+------------------------------------------------+---------------------------------+
| 6. Date on which issuer notified: | 20 January 2009 |
+------------------------------------------------+---------------------------------+
| 7. Threshold(s) that is/are crossed or | Direct/Indirect 9% |
| reached: | |
+------------------------------------------------+---------------------------------+
| 8. Notified details: | |
+------------------------------------------------+------------------------+--------+
+---------------+-------------+-----------+-------------+-----------+------------+----------+----------+
| A: Voting rights attached to shares |
+------------------------------------------------------------------------------------------------------+
| Class/type | Situation previous to | Resulting situation after the triggering |
| of shares | the Triggering | transaction |
| if possible | transaction | |
| using the | | |
| ISIN CODE | | |
+ +-------------------------+------------------------------------------------------------+
| | Number of |Number of | Number of | Number of voting | % of voting |
| | Shares | Voting | shares | rights | rights |
| | | Rights | | | |
+ + + +-------------+------------------------+---------------------+
| | | | Direct | Direct | Indirect | Direct |Indirect |
+---------------+-------------+-----------+-------------+-----------+------------+----------+----------+
| Ord 10p | N/A | N/A | 681,303 | 681,303 | 2,349,790 | 2.160% | 7.451% |
| Shares | | | | | | | |
| ISIN | | | | | | | |
| GB00B1NPJJ01 | | | | | | | |
+---------------+-------------+-----------+-------------+-----------+------------+----------+----------+
+----------------+------------+-------------------+--------------------+------------+
| B: Financial Instruments |
+-----------------------------------------------------------------------------------+
| Resulting situation after the triggering transaction |
+-----------------------------------------------------------------------------------+
| Type of | Expiration | Exercise/ | Number of voting | % of |
| financial | date | Conversion | rights that may be | voting |
| instrument | | Period/ Date | acquired if the | rights |
| | | | instrument is | |
| | | | exercised/ | |
| | | | converted. | |
+----------------+------------+-------------------+--------------------+------------+
| N/A | | | | |
+----------------+------------+-------------------+--------------------+------------+
+--------------------------------------+----------------------------------------+
| Total (A+B) |
+-------------------------------------------------------------------------------+
| Number of voting rights | % of voting rights |
+--------------------------------------+----------------------------------------+
| 3,031,093 | 9.611% |
+--------------------------------------+----------------------------------------+
+-----------------------------------------------------------------------------+
| 9. Chain of controlled undertakings through which the voting rights and/or |
| the financial instruments are effectively held, if applicable: |
+-----------------------------------------------------------------------------+
| 3,031,093 shares (9.611%) are under the control of Insight Investment |
| Management (Global) Limited, a wholly owned subsidiary of Insight |
| Investment Management Limited, a wholly owned subsidiary of HBOS Insurance |
| & Investment Group Limited, a wholly owned subsidiary of HBOS plc, a wholly |
| owned subsidiary of Lloyds Banking Group plc (Indirect Interests). Within |
| these holdings, 644,939 shares (2.045%) are managed on behalf of Clerical |
| Medical investment Group Limited, a wholly owned subsidary of Clerical |
| Medical Investment Group Limited, a wholly owned subsidiary of HBOS |
| Financial Services Limited, a wholly owned subsidiary of HBOS Insurance & |
| Investment Group Limited a wholly owned subsidiary of HBOS plc, a wholly |
| owned subsidiary of Lloyds Banking Group plc, and are therefore disclosed |
| as an overall Direct Interest. |
+-----------------------------------------------------------------------------+
+-------------------------------------------------+----------------------------+
| Proxy Voting: |
+------------------------------------------------------------------------------+
| 10. Name of the proxy holder: | N/A |
+-------------------------------------------------+----------------------------+
| 11. Number of voting rights proxy holder will | N/A |
| cease to hold: | |
+-------------------------------------------------+----------------------------+
| 12. Date on which proxy holder will cease to | N/A |
| hold voting rights: | |
+-------------------------------------------------+----------------------------+
+---------------------------------+--------------------------------------------+
| 13. Additional information: | Notification using the total |
| | voting rights figure of |
| | 31,536,697 |
+---------------------------------+--------------------------------------------+
| 14. Contact name: | Kenny Melville |
+---------------------------------+--------------------------------------------+
| 15. Contact telephone number: | 0131 243 8671 |
+---------------------------------+--------------------------------------------+
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUAUARKNRAUAR
Neuropharm (LSE:NPH)
Historical Stock Chart
From Sep 2024 to Oct 2024
Neuropharm (LSE:NPH)
Historical Stock Chart
From Oct 2023 to Oct 2024
